绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02186 绿叶制药

交易中 11-20 13:45:13

2.620

+0.000

0.00%

最高2.650	最低2.610	成交量579.60万
今开2.630	昨收2.620	日振幅1.53%
总市值98.56亿	流通市值98.56亿	总股本37.62亿
成交额1,524万	换手率0.15%	流通股本37.62亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02186","market":"HK","secType":"STK","nameCN":"绿叶制药","latestPrice":2.62,"timestamp":1732081292734,"preClose":2.62,"halted":0,"volume":5796000,"delay":0,"floatShares":3761670643,"shares":3761670643,"eps":0.15349638,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"11-20 13:45:13","open":2.63,"high":2.65,"low":2.61,"amount":15235625,"amplitude":0.015267,"askPrice":2.62,"askSize":333500,"bidPrice":2.61,"bidSize":164000,"shortable":3,"etf":0,"ttmEps":0.2200646372317822,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1732090200000},"adr":0,"adjPreClose":2.62,"dividendRate":0.024367,"openAndCloseTimeList":[[1732066200000,1732075200000],[1732078800000,1732089600000]],"volumeRatio":0.878272,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02186","defaultTab":"news","newsList":[{"id":"2483438863","title":"绿叶制药11月15日遭主力抛售446万元 环比增加118.63%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483438863","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483438863?lang=zh_cn&edition=full","pubTime":"2024-11-15 16:16","pubTimestamp":1731658584,"startTime":"0","endTime":"0","summary":"11月15日, 绿叶制药股价跌1.48%，报收2.67元，成交金额4070万元，换手率0.41%，振幅3.69%，量比1.16。绿叶制药今日主力资金净流出446万元，上一交易日主力净流出204万元，今日环比增加118.63%。该股近5个交易日下跌6.32%，主力资金累计净流出530万元；近20日主力资金累计净流出5736万元，其中净流出天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161634abc3dfe3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241115161634abc3dfe3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","BK1583","02186","BK1606"],"gpt_icon":0},{"id":"2483092426","title":"南向资金11月12日净买入绿叶制药7.25万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2483092426","media":"市场透视","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483092426?lang=zh_cn&edition=full","pubTime":"2024-11-13 09:30","pubTimestamp":1731461415,"startTime":"0","endTime":"0","summary":"11月12日, 南向资金增持绿叶制药7.25万股，连续3日增持。截止当日收盘，港股通共持有绿叶制药132531.25万股，占流通股35.22%。港股通增持金额前五个股分别为中芯国际、建设银行、中升控股、安踏体育、中国神华。绿叶制药近5个交易日下跌0.36%，港股通累计减持71.00万股；近20个交易日下跌10.00%，港股通累计减持837.30万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093207abbb7f6a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241113093207abbb7f6a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1583","BK1191","02186"],"gpt_icon":0},{"id":"2482022796","title":"绿叶制药创新抗抑郁药LY03021获批临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2482022796","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482022796?lang=zh_cn&edition=full","pubTime":"2024-11-11 14:33","pubTimestamp":1731306826,"startTime":"0","endTime":"0","summary":"财中社11月11日电绿叶制药（02186）发布公告，宣布其1类创新药LY03021已获得中国国家药品监督管理局药品审评中心批准开展临床试验，旨在治疗抑郁症。LY03021是一种新型的抗抑郁药物，采用了针对去甲肾上腺素转运体（NET）、多巴胺转运体（DAT）和GABAA受体的三靶点作用机制，具有同类首创的潜质。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411113235655095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1141","BK1576","BK1606","BK1191","02186","BK1583","03347"],"gpt_icon":0},{"id":"2482287712","title":"绿叶制药：1类创新药LY03021获准开展临床试验 拟用于治疗抑郁症","url":"https://stock-news.laohu8.com/highlight/detail?id=2482287712","media":"每日经济新闻","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482287712?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:34","pubTimestamp":1731299675,"startTime":"0","endTime":"0","summary":"11月11日，绿叶制药在港交所公告，集团的1类创新药LY03021已获得国家药品监督管理局药品审评中心批准开展临床试验，拟用于治疗抑郁症。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202411113235510151.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202411113235510151.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1576","06978","BK1191","BK1141","02186","BK1606","BK1574","BK1161","BK1583","03347"],"gpt_icon":0},{"id":"2482240324","title":"绿叶制药(02186.HK)：集团的1类创新药LY03021已获得中国国家药品监督管理局药品审评中心批准开展临床试验，拟用于治疗抑郁症。","url":"https://stock-news.laohu8.com/highlight/detail?id=2482240324","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482240324?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:19","pubTimestamp":1731298791,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK1191","BK1583","03347","BK1161","06978","BK1141","BK1576","159992","02186","BK1606","BK1574"],"gpt_icon":0},{"id":"2482624042","title":"绿叶制药抗抑郁1类创新药(LY03021)获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2482624042","media":"格隆汇资讯","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482624042?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:19","pubTimestamp":1731298741,"startTime":"0","endTime":"0","summary":"格隆汇11月11日丨绿叶制药宣布，集团的1类创新药LY03021已获得中国国家药品监督管理局药品审评中心批准开展临床试验，拟用于治疗抑郁症。抑郁症是由各种原因引起的，以显着和持久的抑郁症状群为主要临床特征，并损害社会功能的一类心境障碍。现有抗抑郁药总体有效率和治愈率低，且普遍存在起效较慢、残留症状多、复发风险高、不良反应多等局限。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111121904abb4a247&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241111121904abb4a247&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1606","BK1191","06978","BK1576","BK1161","BK1574","03347","BK1583","BK1141","02186"],"gpt_icon":0},{"id":"2482240058","title":"【港股通】绿叶制药(02186)1类创新药LY03021获批临床 拟用于治疗抑郁症","url":"https://stock-news.laohu8.com/highlight/detail?id=2482240058","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482240058?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:17","pubTimestamp":1731298675,"startTime":"0","endTime":"0","summary":"金吾财讯 | 绿叶制药(02186)公布，集团的1类创新药LY03021已获得中国国家药品监督管理局药品审评中心批准开展临床试验，拟用于治疗抑郁症。据悉，LY03021为去甲肾上腺素转运体(“NET”)╱多巴胺转运体(“DAT”)抑制剂、－氨基丁酸A受体正向变构调节剂(GABAARPAM)。该产品基于集团新分子实体╱新治疗实体技术平台(NCE/NTE)自主开发，是全新的三靶点作用机制抗抑郁药物，具有同类首创(First-in-Class)的潜质。据公司所知，目前尚未检索到相同机制的产品在研。","market":"us","thumbnail":"https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20241108/Y2MwODZhYWZmNGQzMDgwOTQyYjU5NWM2YWIxYjEyMTA4MTkwNzMzNjk5.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1947456","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HSCEI","BK1574","YANG","159992","BK1606","HSTECH","06978","02186","BK1583","BK1191","BK1161"],"gpt_icon":0},{"id":"2482155240","title":"绿叶制药(02186)：抗抑郁1类创新药(LY03021)获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2482155240","media":"智通财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482155240?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:11","pubTimestamp":1731298280,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药 公布，该集团的1类创新药LY03021已获得中国国家药品监督管理局药品审评中心批准开展临床试验，拟用于治疗抑郁症。LY03021同时针对NET、DAT和GABAAR三个靶点发挥作用。非临床研究显示，LY03021给药后24小时即显著改善模型动物抑郁症状，且连续用药，药效可维持至为期21天的研究结束时，展现出兼具快速起效和长期连续用药保持疗效的优势。包括抑郁症在内的CNS治疗领域患者需求庞大，但新药研发进展相对较缓。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1209109.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03021","BK1576","06978","BK1191","BK1141","02186","BK1606","BK1574","BK1161","159992","BK1583","03347"],"gpt_icon":0},{"id":"2482240540","title":"绿叶制药(02186.HK)抗抑郁创新药LY03021获准开展临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2482240540","media":"阿斯达克财经","labels":["Product Release"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482240540?lang=zh_cn&edition=full","pubTime":"2024-11-11 12:10","pubTimestamp":1731298200,"startTime":"0","endTime":"0","summary":"绿叶制药(02186.HK) 公布，集团的1类创新药LY03021已获得中国国家药监局药品审评中心批准开展临床试验，拟用于治疗抑郁症。LY03021基于集团新分子实体/新治疗实体技术平台自主开发，是全新的三靶点作用机制抗抑郁药物，具有同类首创(First-in-Class)的潜质。据公司所知，目前尚未检索到相同机制的产品在研。(gc/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-11-08 16:25。)AASTOCKS新闻","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220711102728108_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220711102728108_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1395622/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"Product Release","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02186","BK1574","BK1606","BK1576","BK1161","03347","06978","BK1141","159992","BK1583"],"gpt_icon":0},{"id":"2481234891","title":"阿斯利康在进博会期间达成近30项签约","url":"https://stock-news.laohu8.com/highlight/detail?id=2481234891","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481234891?lang=zh_cn&edition=full","pubTime":"2024-11-08 17:38","pubTimestamp":1731058731,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["AZN","LU2236285917.USD","LU2417539215.USD","BK4585","LU2462157665.USD","BK1606","LU0320765992.SGD","LU1829250122.USD","LU2456880835.USD","BK1191","02186","LU0109394709.USD","BK4568","BK4007","BK1583","LU0889565916.HKD","BK4588"],"gpt_icon":0},{"id":"2481629920","title":"绿叶制药11月06日主力资金流出283万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2481629920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481629920?lang=zh_cn&edition=full","pubTime":"2024-11-06 16:16","pubTimestamp":1730880987,"startTime":"0","endTime":"0","summary":"11月06日, 绿叶制药股价跌1.07%，报收2.77元，成交金额2841万元，换手率0.27%，振幅2.50%，量比0.57。绿叶制药今日主力资金净流出283万元，连续3日净流出，上一交易日主力净流出312万元，今日环比减少9.29%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为47.37%，平均跌幅为2.45%。该股近5个交易日下跌5.46%，主力资金累计净流出1753万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出5603万元，其中净流出天数为16日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161652aba57960&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106161652aba57960&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02186","BK1583","BK1191","BK1606"],"gpt_icon":0},{"id":"2479773085","title":"绿叶制药10月31日遭主力抛售1078万元 环比增加151.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773085?lang=zh_cn&edition=full","pubTime":"2024-10-31 16:16","pubTimestamp":1730362601,"startTime":"0","endTime":"0","summary":"10月31日, 绿叶制药股价跌4.78%，报收2.79元，成交金额8235万元，换手率0.78%，振幅5.12%，量比2.46。绿叶制药今日主力资金净流出1078万元，连续6日净流出，上一交易日主力净流出429万元，今日环比增加151.28%。该股近5个交易日下跌8.31%，主力资金累计净流出3248万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出4678万元，其中净流出天数为15日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161710a2005726&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031161710a2005726&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1191","02186","BK1606","BK1583"],"gpt_icon":0},{"id":"2479695745","title":"绿叶制药(02186)下跌5.12%，报2.78元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2479695745","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479695745?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:55","pubTimestamp":1730346902,"startTime":"0","endTime":"0","summary":"10月31日，绿叶制药(02186)盘中下跌5.12%，截至11:55，报2.78元/股，成交5368.11万元。绿叶制药集团有限公司主要在全球最大和增长最快的四个治疗领域（肿瘤科、中枢神经系统、心血管系统及消化与代谢）进行创新药品的开发、生产、推广及销售，产品组合包括超过30种产品，覆盖全球80个以上国家和地区。关键经营数据显示，2021年，公司产品销售覆盖全国30个省、自治区和直辖市，通过约1000名销售和营销人员以及约1780家经销商网络，产品销往19330多家医院，同时在国际市场覆盖80个国家或地区。截至2024年中报，绿叶制药营业总收入30.75亿元、净利润3.88亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/10/31115544773929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02186","BK1583","BK1606","BK1191"],"gpt_icon":0},{"id":"2479745022","title":"绿叶制药盘中异动 临近午盘股价大跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479745022","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479745022?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:54","pubTimestamp":1730346897,"startTime":"0","endTime":"0","summary":"2024年10月31日临近午盘11时54分，绿叶制药股票出现异动，股价急速下跌5.12%。截至发稿，该股报2.780港元/股，成交量1894.23万股，换手率0.50%，振幅5.12%。资金方面，该股资金流入1596.82万港元，流出2931.63万港元。绿叶制药股票所在的药品行业中，整体跌幅为0.19%。其相关个股中，顺腾国际控股、德琪医药-B、中生联合涨幅较大，振幅较大的相关个股有兴科蓉医药、德琪医药-B、培力农本方，振幅分别为11.90%、10.98%、10.14%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031115457971a36b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031115457971a36b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02186","BK1583","BK1606","BK1191"],"gpt_icon":0},{"id":"2479465637","title":"绿叶制药(02186)股价下跌5.119%，现价港币$2.78","url":"https://stock-news.laohu8.com/highlight/detail?id=2479465637","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479465637?lang=zh_cn&edition=full","pubTime":"2024-10-31 11:54","pubTimestamp":1730346840,"startTime":"0","endTime":"0","summary":"[下跌股]绿叶制药(02186) 股价在上午11:54比前收市价下跌5.119%，现股价为港币$2.78。至目前为止，今日最高价为$2.93，而最低价为$2.78。总成交量为1.894千万股，总成交金额为港币$5.368千万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180725131627024_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD241031794/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1191","02186","BK1583","BK1606"],"gpt_icon":0},{"id":"2479715424","title":"绿叶制药(02186.HK)完成发行1亿美元可转换债券 初步换股价每股3.672港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479715424","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479715424?lang=zh_cn&edition=full","pubTime":"2024-10-31 09:46","pubTimestamp":1730339160,"startTime":"0","endTime":"0","summary":"绿叶制药(02186.HK) 公布，完成发行1亿美元5.85%利率2025年到期可转换债券，预期相关债券在新交所上市将于明日(11月1日)生效，初步换股价为每股3.672港元。绿叶制药表示，通过是次债券发行可以改善集团的资金流动性，以及替换集团部分短期贷款。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-10-30 16:25。)AASTOCKS新闻","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220711103353187_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220711103353187_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1392772/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02186","BK1583","BK1606","BK1191"],"gpt_icon":0},{"id":"2479784875","title":"绿叶制药(02186)完成发行1亿美元可转换债券","url":"https://stock-news.laohu8.com/highlight/detail?id=2479784875","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479784875?lang=zh_cn&edition=full","pubTime":"2024-10-30 22:36","pubTimestamp":1730298964,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药(02186)公布，有关公司发行1亿美元5.85%利率2025年到期可转换债券(A期债券)，A期认购协议所载发行A期债券的所有先决条件已获达成，且发行A期债券已顺利完成。预期A期债券于新交所上市将于2024年11月1日生效。债券的初步换股价为每股3.672港元。董事会认为通过A期债券发行可以改善集团的资金流动性以及替换集团部分短期贷款。董事会认为，是次发行A期债券所得款项净额将减少集团的资金成本并改善集团的债务到期情况。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204340.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","BK1606","BK1583","02186"],"gpt_icon":0},{"id":"2479715462","title":"绿叶制药拟变更1亿美元5.85%利率2025年到期可转换债券A期交割日为10月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2479715462","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479715462?lang=zh_cn&edition=full","pubTime":"2024-10-29 07:27","pubTimestamp":1730158024,"startTime":"0","endTime":"0","summary":"绿叶制药（02186）发布公告，兹提述内容有关公司发行1亿美元5.85%利率2025年到期可转换债券。\n　　公司宣布公司与认购人已同意变更A期交割日为2024年10月30日，或公司与认购人可能协定的较后日期。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-29/doc-incuehum8146971.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-10-29/doc-incuehum8146971.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_sina","symbols":["BK1191","BK1606","BK1583","02186"],"gpt_icon":0},{"id":"2478821654","title":"绿叶制药(02186)拟变更1亿美元5.85%利率2025年到期可转换债券A期交割日为10月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2478821654","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478821654?lang=zh_cn&edition=full","pubTime":"2024-10-28 22:33","pubTimestamp":1730126028,"startTime":"0","endTime":"0","summary":"智通财经APP讯，绿叶制药(02186)发布公告，兹提述内容有关公司发行1亿美元5.85%利率2025年到期可转换债券。公司宣布公司与认购人已同意变更A期交割日为2024年10月30日，或公司与认购人可能协定的较后日期。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201861.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","02186","BK1583","BK1606"],"gpt_icon":0},{"id":"2478642250","title":"中庚基金披露三季报!丘栋荣离任后累计净赎回超20亿份","url":"https://stock-news.laohu8.com/highlight/detail?id=2478642250","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478642250?lang=zh_cn&edition=full","pubTime":"2024-10-25 11:03","pubTimestamp":1729825405,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，10月24日，中庚基金旗下产品披露三季报，多只基金出现明显的净赎回。随着知名基金经理丘栋荣的离任，中庚基金三季度累计净赎回超过20亿份。其中，中庚价值领航是中庚基金管理规模最大的基金，三季度末规模达46.89亿元。该基金的总份额从期初的22.58亿份降至期末的19.24亿份，三季度净赎回超过3亿份。具体来看，中庚价值领航在三季度末维持高仓位运行，股票仓位达到92.79%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1199555.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02186","LU1979443071.USD","LU0128522157.USD","BK1175","HK0000306701.USD","LU0181495838.USD","IE00BZ08YR35.GBP","LU0231483743.USD","LU0049853897.USD","LU0214875030.USD","002928","HK0000320264.USD","BK0240","LU0164865239.USD","BK0155","00123","BK1583","LU0072462343.USD","300761","IE00B5MMRT66.SGD","IE00B0JY6N72.USD","SG9999001093.SGD","002714","IE00B543WZ88.USD","LU0132412106.USD","01378","LU0228367735.SGD","BK0195","BK1606","IE00B3M56506.USD","BABA","BK0242","09863","000422","LU0054450605.USD","BK1584","BK0188","BK0056","HK0000306685.HKD","BK0070","89988","BK1501","LU0127658192.USD","BK1119","BK1608","LU0149721374.USD","09988","601168","LU0106252389.USD","IE00BMPRXN33.USD"],"gpt_icon":1}],"profile":{"websiteUrl":"http://www.luye.cn","stockEarnings":[{"period":"1week","weight":-0.0609},{"period":"1month","weight":-0.1813},{"period":"3month","weight":-0.0643},{"period":"6month","weight":-0.0296},{"period":"1year","weight":-0.3282},{"period":"ytd","weight":-0.2976}],"compareEarnings":[{"period":"1week","weight":-0.0092},{"period":"1month","weight":-0.0548},{"period":"3month","weight":0.1307},{"period":"6month","weight":0.0421},{"period":"1year","weight":0.1061},{"period":"ytd","weight":0.1535}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"绿叶制药集团有限公司是一家主要从事开发、生产、推广及销售药品的投资控股公司。公司及其子公司通过四大分部运营：肿瘤药物分部、心血管系统药物分部、消化与代谢药物分部和其他分部。该公司的主要产品包括用于癌症的化学治疗的备紫杉醇类制剂，用于实体肿瘤的放射治疗的注射用化合物，用于治疗高脂血症治疗的中药，用于治疗二型糖尿病的阿卡波糖胶囊，用于治疗老年痴呆症的卡巴拉汀透皮贴片等。产品以力扑素，希美纳，血脂康，麦通纳，贝希等品牌销售。该公司通过其子公司还从事提供合约研究及程序开发业务。该公司主要在中国内地运营业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":-0.026366},{"month":2,"riseRate":0.3,"avgChangeRate":0.013725},{"month":3,"riseRate":0.4,"avgChangeRate":-0.015714},{"month":4,"riseRate":0.5,"avgChangeRate":-0.00409},{"month":5,"riseRate":0.3,"avgChangeRate":-0.034213},{"month":6,"riseRate":0.3,"avgChangeRate":-0.003238},{"month":7,"riseRate":0.6,"avgChangeRate":-0.000283},{"month":8,"riseRate":0.181818,"avgChangeRate":-0.034124},{"month":9,"riseRate":0.636364,"avgChangeRate":0.054933},{"month":10,"riseRate":0.545455,"avgChangeRate":0.000249},{"month":11,"riseRate":0.545455,"avgChangeRate":0.031888},{"month":12,"riseRate":0.4,"avgChangeRate":0.009706}],"exchange":"SEHK","name":"绿叶制药","nameEN":"LUYE PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"绿叶制药,02186,绿叶制药股票,绿叶制药股票老虎,绿叶制药股票老虎国际,绿叶制药行情,绿叶制药股票行情,绿叶制药股价,绿叶制药股市,绿叶制药股票价格,绿叶制药股票交易,绿叶制药股票购买,绿叶制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"绿叶制药(02186)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供绿叶制药(02186)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}